Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
HER2-driven mammary tumorigenesis enhances bioenergetics despite reductions in mitochondrial content
Sara M Frangos1, Henver S Brunetta1, Dongdong Wang2,3
1Department of Human Health Sciences, University of Guelph, Guelph, Canada.
Abstract:
It is now recognized that mitochondria play a crucial role in tumorigenesis; however, it has become clear that tumor metabolism varies significantly between cancer types. The failure of recent clinical trials aimed at directly targeting tumor respiration through oxidative phosphorylation inhibitors underscores the critical need for further studies providing an in-depth evaluation of mitochondrial bioenergetics. Accordingly, we comprehensively assessed the bulk tumor and mitochondrial metabolic phenotype in murine HER2-driven mammary cancer tumors and benign mammary tissue. Transcriptomic and proteomic profiling revealed a broad downregulation of mitochondrial genes/proteins in tumors, including OXPHOS subunits comprising Complexes I-IV. Despite reductions in tumor mitochondrial proteins, mitochondrial respiration was several-fold higher compared to benign mammary tissue, which persisted regardless of normalization method (wet weight, total protein content, and when corrected for mitochondrial content). This upregulated respiratory capacity could not be explained by OXPHOS uncoupling, suggesting HER2 signaling regulates intrinsic mitochondrial bioenergetics. In further support, lapatinib, an EGFR/HER2 tyrosine kinase inhibitor, attenuated mitochondrial respiration in NF639 murine mammary tumor epithelial cells. Together, this data highlights that the typical correlation between mitochondrial content and respiratory capacity may not apply to all tumor types and implicates HER2-linked activation of mitochondrial respiration supporting tumorigenesis in this model.
Insights
Mitochondria are key in cancer, but tumor metabolism varies. This study found higher mitochondrial respiration in HER2-positive breast tumors than expected, suggesting HER2 signaling drives this bioenergetic shift.
Area of Science:
- Oncology
- Mitochondrial Biology
- Cancer Metabolism
Background:
- Mitochondria are crucial in tumorigenesis, but tumor metabolism differs across cancer types.
- Previous attempts to target tumor respiration via oxidative phosphorylation inhibitors have failed.
- Understanding mitochondrial bioenergetics in diverse tumors is critical.
Purpose of the Study:
- To comprehensively assess the metabolic phenotype of mitochondria in murine HER2-driven mammary cancer.
- To investigate the relationship between mitochondrial content and respiratory capacity in tumors.
- To explore the role of HER2 signaling in regulating mitochondrial bioenergetics.
Main Methods:
- Transcriptomic and proteomic profiling of murine HER2-driven mammary tumors and benign mammary tissue.
- Measurement of mitochondrial respiration using various normalization methods.
- Assessment of the effect of lapatinib (EGFR/HER2 inhibitor) on mitochondrial respiration in tumor cells.
Main Results:
- Tumors showed downregulation of mitochondrial genes and proteins, including oxidative phosphorylation (OXPHOS) subunits.
- Despite reduced mitochondrial proteins, tumor mitochondrial respiration was significantly higher than in benign tissue.
- This increased respiration was not due to OXPHOS uncoupling and was attenuated by lapatinib treatment.
Conclusions:
- The correlation between mitochondrial content and respiratory capacity may not hold true for all tumor types.
- HER2 signaling appears to intrinsically regulate mitochondrial bioenergetics, enhancing respiration.
- HER2-linked activation of mitochondrial respiration supports tumorigenesis in this model.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitogens and the Cell Cycle

